Columbus McKinnon (CMCO) Q1 2027 earnings review
Kito Crosby Deal Transforms Top Line and Turbocharges Margins
Columbus McKinnon delivered a stellar first full quarter post-Kito Crosby acquisition, posting a massive 125% YoY revenue surge to $531.5 million. More importantly, the organic engine is firing on all cylinders, with Legacy CMCO sales growing 12.7%. While GAAP net income printed an ugly $88.7 million loss due to heavy integration and inventory step-up costs, the underlying earnings power is accelerating rapidly. Adjusted EBITDA surged 242% to $111.5 million, pushing margins to 21.0% (up 720 bps YoY). Management confidently raised full-year FY27 guidance across the board, signaling that synergy capture and U.S. demand are tracking well ahead of schedule.
🐂 Bull Case
The immediate 720 bps expansion in Adjusted EBITDA margin to 21.0% proves the Kito Crosby integration is accretive right out of the gate. Management raised full-year Adjusted EBITDA guidance to $405-$420M.
A 12.7% organic growth rate in the Legacy CMCO business, combined with a 1.1x book-to-bill ratio, highlights that U.S. short-cycle demand has stabilized and is actively accelerating.
🐻 Bear Case
The company reported a massive $88.7M GAAP net loss. A $55.2M inventory step-up and $15.3M in integration costs severely punish statutory earnings, requiring investors to blindly trust the 'adjusted' metrics.
Despite strong cash flow, the Credit Agreement Net Leverage Ratio remains elevated at 4.9x. The aggressive debt paydown schedule could be derailed if EMEA macro conditions worsen.
⚖️ Verdict: 🟢
Bullish. Management is executing the massive Kito Crosby integration near-flawlessly. The combination of double-digit organic growth, massive margin expansion, and a 'beat and raise' quarter validates the strategic logic of the acquisition.
Key Themes
Kito Crosby Synergies Turbocharge Margins
Adjusted EBITDA margin expanded by a staggering 720 basis points YoY to 21.0%, up from 13.8% in the prior-year period. Management specifically pointed to the accretive impact of the Kito Crosby deal and aggressive synergy realization. This is a clear indicator that the integration is tracking ahead of the company's long-term $70M run-rate goal.
Legacy CMCO Organic Growth Accelerating
Legacy CMCO net sales grew 12.7%, defying broader industrial softness. The 1.1x book-to-bill ratio and 120% total order growth to $568.1M show that U.S. short-cycle demand remains highly robust, validating management's pivot toward high-growth verticals and overcoming the choppy macro environment.
Intelligent Motion & Product Cross-Selling
The combination is creating a formidable product portfolio. Integrating Kito Crosby's rigging and lifting hardware consumables with Legacy CMCO's precision conveyance and linear motion systems allows the company to offer holistic solutions, heavily driving the $292.7M in U.S. sales (up 116% YoY).
GAAP Net Income Crushed by Deal Costs
While adjusted metrics paint a rosy picture, GAAP Net Income remains in deep negative territory at a loss of $88.7M. This was driven by a staggering $55.2M acquisition inventory step-up and $15.3M in integration costs. The severe divergence between GAAP ($-2.05 EPS) and Adjusted EPS ($0.61) requires close monitoring; if integration costs remain elevated into FY28, the adjusted figures will lose credibility.
Balance Sheet Leverage Remains Elevated
The Credit Agreement Net Leverage Ratio sits at 4.9x, down only slightly from 5.1x in Q4 FY26. Management's stated priority is to aggressively de-lever to <4.0x. While strong cash generation is promising, holding nearly $2.4B in debt at current interest rates limits capital allocation flexibility.
Diverging Regional Demand (EMEA Weakness)
Management's prior warnings about worsening geopolitical conditions and slower project conversions in EMEA remain a lingering risk factor. With 45% of Q1 sales ($238.8M) originating outside the U.S., any further deterioration in the European macro environment could offset the undeniable strength seen in U.S. markets.
Material Cost Benefits Mask Underlying Margin Baseline
In FY26, tariffs were a persistent $10M headwind. This quarter, management cited 'benefits to material costs that were specific to the quarter' as a driver of the gross margin expansion to 38.1%. This suggests some of the current quarter's margin beat is transient and not purely driven by structural pricing power or permanent synergies.
Other KPIs
Reversing. FCF dramatically improved from a use of cash in Q1 FY26. Stripping out $12.5M in cash payments related to the Kito Crosby integration, core FCF was $32.4M. This highlights the strong cash engine of the newly combined company, which is critical for meeting their deleveraging targets.
Accelerating. Up 380 basis points YoY. This reflects positive pricing actions, volume leverage from the 12.7% legacy growth, and the structural gross margin uplift brought in by the Kito Crosby portfolio.
Guidance
Accelerating. Management raised the lower end of their prior outlook ($2.05B - $2.12B). The new midpoint of $2.12B signals confidence in translating the 1.1x book-to-bill ratio and current backlog into recognized revenue despite global macro volatility.
Accelerating. Raised from the previous range of $390M to $410M. The new midpoint ($412.5M) implies an adjusted EBITDA margin of ~19.5% for the full year. Because Q1 printed at 21.0%, this implies a slight deceleration in margin for the rest of the year, likely factoring out the 'specific quarter' material cost benefits.
Accelerating. A significant bump from the prior $1.70 to $1.90 range. This accounts for roughly $185M-$190M of interest expense burden and assumes 52 million adjusted diluted shares outstanding (as preferred dividends will accrue rather than be paid in cash).
Key Questions
Sustainability of Q1 Margins
Adjusted EBITDA margin hit an impressive 21.0% this quarter, but the raised FY27 guidance implies a full-year margin closer to 19.5%. How much of the Q1 beat was driven by the 'specific material cost benefits' mentioned, and should we expect sequential margin compression in Q2?
EMEA Macro Impact
Non-U.S. sales represent 45% of total revenue. With ongoing geopolitical issues and economic softness previously flagged in EMEA, are you seeing any concrete stabilization in international project conversions, or is U.S. demand entirely masking overseas weakness?
Deleveraging Timeline
You successfully stepped down leverage to 4.9x this quarter. Given the robust $32.4M in Free Cash Flow excluding deal costs, do you still expect it will take two full years to dip below the 4.0x leverage target, or could synergy acceleration pull that timeline forward?